Contact Jacoby & Meyers
Dangerous Drug Lawyers
Call us Today 800-977-5614

Jalyn is a combination of dutasteride and tamsulosin. It works to prevent the conversion of testosterone to dihydrotesterone (DHT). DHT is one of the causes of benign prostatic hyperplasia (BPH). Jalyn is used to treat BPH in men with an enlarged prostate. It is classified as a 5-alpha reductase inhibitor (5-ARI).
In two studies, the Prostate Cancer Prevention Trial (PCPT) and the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial, Jalyn, and drugs similar to it, were linked to an increased risk of high-grade prostate cancer.
Both studies found that while the drugs decreased the risk of developing lower-risk forms of prostate cancer by as much as 26 percent, it increased the risk of developing a higher-grade version, which spreads more rapidly.
Jalyn has also been linked to sexual side effects including less desire for sex, erectile dysfunction, decrease in the amount of semen, problems with ejaculation, gynecomastia, impotence, testicular pain and male breast cancer.
Serious side effects may include:
Lawyer Advertising. This website is designed for general information only, and in no way is intended to constitute legal advice nor the formation of a lawyer/client relationship without a signed, written agreement. Testimonials or endorsements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. You pay no fees or costs unless we recover for you. This website contains dramatizations. Prior results are not a guarantee of a future outcome. Jacoby & Meyers does not accept all cases and works cooperatively with co-counsel and/or other law firms with whom it has joint agreements who might potentially handle your cases. We look forward to helping you with your claim.
© 2012-2025 Jacoby & Meyers. All rights reserved.